Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$13.84
-0.10-0.75%
Last update: Oct 6, 12:32 PM
$14.29
0.352.51%
Crescent Biopharma Inc (CBIO) Stock Price, Quote, News & History
CBIONASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Crescent Biopharma Inc is a biopharmaceutical company developing novel therapeutics to treat solid tumors, led by CR-001, a proprietary anti-PD-1/anti-VEGF bispecific antibody. Crescent's pipeline product CR-001 has the potential to deliver improved...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Crescent Biopharma (NASDAQ:CBIO) through any online brokerage.
Other companies in Crescent Biopharma’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Crescent Biopharma has a consensus price target of $29.00.
The stock price for Crescent Biopharma (NASDAQ: CBIO) is $13.835 last updated October 6, 2026 at 12:32 PM EDT.
There are no upcoming dividends for Crescent Biopharma.
Crescent Biopharma does not have any upcoming earnings scheduled.
There is no upcoming split for Crescent Biopharma.
Crescent Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
